Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
362 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Closed (3)

Medical Condition

  • Show all (240)
  • Addiction (4)
  • Autoimmune Disorders (15)
  • Blood Disorders (27)
    • Amyloidosis (11)
    • (-) Anemia (1)
    • Sickle Cell Disease (1)
  • Bone & Muscle (1)
  • Cancer (4)
  • Child Development (1)
  • Developmental Disorders (1)
  • Endocrine & Metabolic Disease (2)
  • Hair and Skin Disorders (2)
  • Healthy Volunteers (8)
  • Heart Disease (1)
  • Liver Disease (1)
  • Lung Disease (2)
  • Meniere's Disease (1)
  • Neurological Disorders (114)
  • Obstetrics & Gynecology (3)
  • Pediatrics (6)
  • Psychiatric Disorders (47)
    • ADD/ADHD (2)
    • Anxiety (4)
    • Bipolar Disorder (6)
    • Borderline Personality Disorder (1)
    • Depression (19)
    • Eating Disorders (2)
    • Obsessive Compulsive Disorder (OCD) (5)
    • PTSD (2)
    • (-) Schizophrenia (2)
Displaying 1 - 3 of 3

A Study to Test if TV-46000 is Effective for Maintenance Treatment of Schizophrenia

Condition: Psychiatric Disorders / Schizophrenia
Investigator: Joshua Kantrowitz, Md
Status: Closed
The purpose of this study is to evaluate the efficacy, safety and tolerability of different doses and durations of TV-46000 given by subcutaneous (under the skin) injection as compared to placebo for use as a potential maintenance in adults with schizophrenia.
Read More

Lumateperone for Schizophrenia

Condition: Psychiatric Disorders / Schizophrenia
Investigator: Jeffrey Lieberman, MD
Status: Closed
This study plans to learn more about an investigational new drug called lumateperone tosylate (ITI-007) and may help us find new types of treatment for schizophrenia and schizoaffective disorder.
Read More

A study for patients with Iron Refractory Iron-Deficiency Anemia (IRIDA) using study drug Triferic

Condition: Blood Disorders / Anemia
Investigator: Katherine Ender, MD
Status: Closed
The main purpose of the study is to find out whether Triferic, when taken by mouth (orally) with Shohls solution, is safe and effective for the treatment of Iron Refractory Iron-Deficiency Anemia (IRIDA). The study drug, ferric pyrophosphate citrate (FPC), is also called Triferic. It is an iron salt that has been approved by the Food and Drug Administration…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science